Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction

References

• Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223–41
   PubMed Web of Science ®Google Scholar
• Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, Hutchinson WL, et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 2010;468:93–7
   PubMed Web of Science ®Google Scholar
• Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649–55
   PubMed Web of Science ®Google Scholar
• Cheng AS, Banning AP, Mitchell AR, Neubauer S, Selvanayagam JB. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. Int J Cardiol 2006;113:E21–3
   Google Scholar
• Ruberg FL, Appelbaum E, Davidoff R, Ozonoff A, Kissinger KV, Harrigan C, Skinner M, et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 2009;103:544–9
   PubMed Web of Science ®Google Scholar
• Krombach GA, Hahn C, Tomars M, Buecker A, Grawe A, Günther RW, Kühl HP. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 2007;25:1283–7
   PubMed Web of Science ®Google Scholar
• Sparrow P, Amirabadi A, Sussman MS, Paul N, Merchant N. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis. J Magn Reson Imaging 2009;30:942–6
   PubMedGoogle Scholar
• Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186–93
   PubMed Web of Science ®Google Scholar
• Hosch W, Kristen AV, Libicher M, Dengler TJ, Aulmann S, Heye T, Schnabel PA, et al. Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings. Amyloid 2008;15:196–204
   PubMed Web of Science ®Google Scholar
• Kwong RY, Falk RH. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:122–4
   PubMedGoogle Scholar
• Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L, Salvi F, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006;92:343–9
   PubMed Web of Science ®Google Scholar
• Hosch W, Bock M, Libicher M, Ley S, Hegenbart U, Dengler TJ, Katus HA, et al. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol 2007;42:636–42
   PubMedGoogle Scholar
• Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234–42
   PubMed Web of Science ®Google Scholar
• Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138–44
   PubMed Web of Science ®Google Scholar
• Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging 2008;24:61–8
   PubMedGoogle Scholar
• Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010;3:727–34
   PubMed Web of Science ®Google Scholar
• Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011;13:16--29
   PubMed Web of Science ®Google Scholar
• Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012;33:1268–78
   PubMed Web of Science ®Google Scholar
• White SK, Sado DM, Flett AS, Moon JC. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart 2012;98:773–9
   PubMed Web of Science ®Google Scholar
• Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 2012;14:64--71
   PubMedGoogle Scholar
• Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 2004;20:588–93
   PubMed Web of Science ®Google Scholar
• Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013;6:34–9
   PubMed Web of Science ®Google Scholar
• Simons P, Al-Shawi R, Ellmerich S, Slamova I, Bodin K, Minogue S, Pepys MB, et al. Controllable expression of SAA in transgenic mice: a refined model of systemic amyloidosis. Amyloid 2010;17:45–6
   Google Scholar
• Botto M, Hawkins PN, Bickerstaff MCM, Herbert J, Bygrave AE, McBride A, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med 1997;3:855–9
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355–64
   Web of Science ®Google Scholar
• Price AN, Cheung KK, Cleary JO, Campbell AE, Johannes R, Lythgoe MF. Cardiovascular magnetic resonance imaging in experimental models. Open Cardiovasc Med J 2010;4:278–92
   PubMedGoogle Scholar
• Riegler J, Cheung KK, Man YF, Cleary JO, Price AN, Lythgoe MF. Comparison of segmentation methods for MRI measurement of cardiac function in rats. J Magn Reson Imaging 2010;32:869–77
   PubMedGoogle Scholar
• Heiberg E, Wigstrom L, Carlsson M, Bolger A, Karlsson M. Time resolved three-dimensional automated segmentation of the left ventricle. Comput Cardiol 2005;32:599–602
   Google Scholar
• Tofts PS, Berkowitz BA. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson Imaging 1994;12:81–91
   PubMedGoogle Scholar
• Kober F, Iltis I, Izquierdo M, Desrois M, Ibarrola D, Cozzone P, Bernard M. High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn Reson Med 2004;51:62–7
   PubMed Web of Science ®Google Scholar
• Campbell-Washburn AE, Price AN, Wells JA, Thomas DL, Ordidge RJ, Lythgoe MF. Cardiac arterial spin labeling using segmented ECG-gated look-locker FAIR: variability and repeatability in preclinical studies. Magn Reson Med 2013;69:238–47
   PubMedGoogle Scholar
• Campbell A, Josephs O, Lythgoe M, Ordidge R, Thomas D. A semi-automatic k-space despiking algorithm for the removal of striping artefact in MRI images. Proc of the 20th International Society for Magnetic Resonance in Medicine Annual Meeting, Melbourne, Australia, 2012: abstract 2433
   Google Scholar
• Healey JF. Statistics: a tool for social research. 5th ed. Belmont, CA: Wadsworth Publ.; 1999
   Google Scholar
• Wang Y, Spiller M, Caravan P. Evidence for weak protein binding of commercial extracellular gadolinium contrast agents. Magn Reson Med 2010;63:609–16
   PubMedGoogle Scholar
• Price AN, Cheung KK, Lim SY, Yellon DM, Hausenloy DJ, Lythgoe MF. Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T. J Cardiovasc Magn Reson 2011;13:44--52
   PubMedGoogle Scholar
• Protti A, Sirker A, Shah AM, Botnar R. Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine-FLASH versus inversion recovery. J Magn Reson Imaging 2010;32:878–86
   PubMedGoogle Scholar
• Brillet G, Dubois M, Beaufils H, Bourbouze R, Deray G. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats. Invest Radiol 1994;29:352–4
   PubMed Web of Science ®Google Scholar